Contemporary Pediatrics Staff

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

A recap of the top pediatric clinical trial results and pipeline data readouts during October 2026.

A recap of the top FDA approvals, regulatory decisions, and pipeline updates affecting pediatric care during October 2026.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Johns Hopkins Children's Center experts outline pedestrian, burn, allergy, anxiety, and candy guidance pediatricians can share before Halloween.

Missed the AAP's new congenital measles guidance? This easy-to-read FAQ covers what pediatric clinicians need to know.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

A Contemporary Pediatrics Peer Exchange panel reviews RSV risk, testing, maternal vaccination, and long-acting monoclonal antibodies, and where infants still slip through the cracks.

Missed the AAP's new pediatric UTI guideline? This easy-to-read FAQ covers the key changes in diagnosis, treatment, imaging, and prevention.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Diana F. Clarke, PharmD, explains how IMPAACT 2023 supported dolutegravir from birth, plus dosing tips and open questions for preterm infants.

AAP’s 2026 conference will bring pediatricians updates on AI, vaccines, misinformation, nutrition, mental health, and clinical care.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

The latest IDSA histoplasmosis update adds a consensus statement on severe disease and outlines when children with pulmonary infection warrant itraconazole therapy.

ISPAD, EASD, and ADA urge pediatric diabetes teams to build center-specific transition policies, use readiness checklists, and ensure timely handoffs to adult clinicians.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

This FAQ breaks down the AAP's newest COVID-19, RSV, and influenza recommendations for clinicians who want a quick refresher on what changed for the 2026-2027 season.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

The AAP's updated clinical report revises screening timelines, ferritin thresholds, and treatment protocols for pediatric iron deficiency and iron deficiency anemia.

Phase 3 data show lebrikizumab improved skin clearance, itch, and quality of life in children with moderate-to-severe atopic dermatitis.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

The AAP recommends annual flu vaccination for all children aged 6 months and older and updates antiviral guidance for the 2026–2027 season.

This FAQ breaks down the AAP's updated pediatric drowning prevention policy, covering supervision, water competency, life jackets, and rescue.

A 173-mother cohort study found parenting role models—not income alone—drove the link between maternal education and COVID-19 vaccination intent.

CTx-1301 improved clinician-rated ADHD symptoms versus placebo in a phase 3 pediatric trial, but detailed safety data remain limited.

Ensitrelvir adds an FDA-approved COVID-19 postexposure prophylaxis option for adults and adolescents aged 12 years or older.

FDA cleared Masimo's pediatric Patient State Index, a SedLine EEG-based sedation score calibrated for children aged 4 and older.